Delivery Order SPE2DB25D3201-SPE2DB25FNVDE
Award Date 7/25/25
Potential Completion Date 7/28/25
Potential Value $4.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $2,728.48 on July 22, 2025, for the supply of Aranespâ„¢ 40 mcg/0.4 mL syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 23, 2025, with performance occurring at the vendor's Conshohocken, Pennsylvania facility. The award carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete in...
- The Defense Logistics Agency awarded a $1,483.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Aranespß 60 mcg/0.3 mL syringes on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside contract represents a small-value pharmaceutical supply transaction fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. The delivery order falls under AmerisourceBergen's...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,880.65 firm fixed-price contract is to provide Aranesp 200 MCG/0.4 ML syringes. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,529.79 firm fixed-price delivery order is for Aranesp 300 MCG/0.6 ML syringes and has a completion date of January 3, 2024. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,529.80 firm fixed-price delivery order is for the supply of Aranesp 500 MCG/1 ML syringes and has an ultimate completion date of November 7, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,657.80 firm fixed-price delivery order is for the provision of Aranesp 25 mcg/0.42 mL syringes, a specialty pharmaceutical product. The award does not have a set-aside designation and has an ultimate completion date of August 14, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several indefinite delivery contracts...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,173.37 award is for the supply of 60 mcg/0.3 ml syringes of Aranesp, a medication used to treat anemia. The contract does not have a set-aside designation, indicating open competition. The ultimate completion date is June 16, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,839.98 firm fixed-price delivery order is for the supply of 4,568,152,958 units of the drug Aranesp 500 MCG/1 ML SYRINGEML. The contract has a period of performance through May 7, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,985.76 by the Defense Logistics Agency (DLA) on July 24, 2025. The contract calls for the delivery of Aranesp 25 micrograms/0.42 milliliter syringes, a medication used to treat anemia in patients with chronic kidney disease and cancer patients undergoing chemotherapy. This is a firm fixed-price delivery order with an ultimate completion date of...
- This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ARANESP 100 MCG/0.5 ML SYRINGE 0.5ML. The award has a total ceiling value of $16,141.52 and an ultimate completion date of April 15, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...